![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » Firm's Stroke Treatment Begins Second Round of Tests
Firm's Stroke Treatment Begins Second Round of Tests
April 7, 2005
Tucson, Ariz.-based ImaRx Therapeutics announced the beginning of treatment for the first patient in a new Phase II clinical trial for its stroke treatment. The company's SonoLysis is being evaluated for safety and effectiveness during clinical trials, which are expected to continue throughout the year. The treatment is designed to clear blood clots quickly without the use of surgery or drugs.
The Business Journal (http://phoenix.bizjournals.com/phoenix/stories/2005/04/04/daily24.html)
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct